These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 22369187)
1. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain. Plosker GL; Lyseng-Williamson KA CNS Drugs; 2012 Apr; 26(4):367-73. PubMed ID: 22369187 [TBL] [Abstract][Full Text] [Related]
2. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain. Plosker GL Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Karlsson M; Berggren AC Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841 [TBL] [Abstract][Full Text] [Related]
4. Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial. Conaghan PG; O'Brien CM; Wilson M; Schofield JP Osteoarthritis Cartilage; 2011 Aug; 19(8):930-8. PubMed ID: 21477658 [TBL] [Abstract][Full Text] [Related]
7. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Sittl R; Griessinger N; Likar R Clin Ther; 2003 Jan; 25(1):150-68. PubMed ID: 12637117 [TBL] [Abstract][Full Text] [Related]
8. Buprenorphine for chronic pain. Calderon R; Copenhaver D J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):402-5. PubMed ID: 24245573 [TBL] [Abstract][Full Text] [Related]
9. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Likar R; Kayser H; Sittl R Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176 [TBL] [Abstract][Full Text] [Related]
10. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
11. [Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study]. Wahle K; Krings D; Schwenke K MMW Fortschr Med; 2013 Mar; 155 Suppl 1():25-31. PubMed ID: 23678668 [TBL] [Abstract][Full Text] [Related]
12. Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study. Karlsson J; Söderström A; Augustini BG; Berggren AC Curr Med Res Opin; 2014 Apr; 30(4):575-87. PubMed ID: 24320787 [TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine (Butrans) for chronic pain. Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, double-dummy comparison of the efficacy and tolerability of low-dose transdermal buprenorphine (BuTrans seven-day patches) with buprenorphine sublingual tablets (Temgesic) in patients with osteoarthritis pain. James IG; O'Brien CM; McDonald CJ J Pain Symptom Manage; 2010 Aug; 40(2):266-78. PubMed ID: 20541900 [TBL] [Abstract][Full Text] [Related]
15. Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management. O'Brien T; Ahn JS; Chye R; Le B; Lu H; Olarte G; Palladini M; Salti A; Shao YY; Yaakup H; Buemio KC; Colin CG; Hadjiat Y J Opioid Manag; 2019; 15(2):147-158. PubMed ID: 31343716 [TBL] [Abstract][Full Text] [Related]
16. Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis. Stanicic F; Grbic D; Vukicevic D; Zah V J Comp Eff Res; 2024 Aug; 13(8):e230183. PubMed ID: 39012387 [No Abstract] [Full Text] [Related]
17. Buprenorphine in long-term control of chronic pain in cancer patients. Pace MC; Passavanti MB; Grella E; Mazzariello L; Maisto M; Barbarisi M; Baccari E; Sansone P; Aurilio C Front Biosci; 2007 Jan; 12():1291-9. PubMed ID: 17127381 [TBL] [Abstract][Full Text] [Related]
18. A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain. Ripa SR; McCarberg BH; Munera C; Wen W; Landau CJ Expert Opin Pharmacother; 2012 Jun; 13(9):1229-41. PubMed ID: 22409388 [TBL] [Abstract][Full Text] [Related]
20. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]